Tandem Diabetes (TNDM) Tops Q4 EPS by 9c, Revenues Miss; Offers FY20 Revenue Guidance Above Consensus

Go back to Tandem Diabetes (TNDM) Tops Q4 EPS by 9c, Revenues Miss; Offers FY20 Revenue Guidance Above Consensus
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 14.41 --0 (-0%)
Previous Close $14.41    52 Week High $12.48 
Open $14.41    52 Week Low $1.60 
Day High $14.41    P/E N/A 
Day Low $14.41    EPS $-6.33 
Volume 705